The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

(2013) L. Matthews et al.   NEUROLOGY

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Epidemiology of Neuromyelitis Optica in the United States

(2012) Maureen A. Mealy et al.   ARCHIVES OF NEUROLOGY

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

(2012) Sven Jarius et al.   Journal of Neuroinflammation

Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?

(2012) Su-Hyun Kim et al.   Multiple Sclerosis Journal

Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod

(2012) Sebastian Jander et al.   Multiple Sclerosis Journal

Does natalizumab therapy worsen neuromyelitis optica?

(2012) A. Jacob et al.   NEUROLOGY

Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis

(2012) T. Sinnecker et al.   NEUROLOGY

Tumefactive multiple sclerosis lesions under fingolimod treatment

(2012) F. Visser et al.   NEUROLOGY

Clinical Usefulness of Cell-based Indirect Immunofluorescence Assay for the Detection of Aquaporin-4 Antibodies in Neuromyelitis Optica Spectrum Disorder

(2012) Eun-suk Kang et al.   Annals of Laboratory Medicine

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder

(2011) Woojun Kim et al.   Multiple Sclerosis Journal

Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4

(2011) Woojun Kim et al.   Multiple Sclerosis Journal

Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders

(2011) Piyush Banker et al.   Multiple Sclerosis Journal

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

(2011) MH Barnett et al.   Multiple Sclerosis Journal

Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder

(2011) Ju-Hong Min et al.   Multiple Sclerosis Journal

Comparative Brain Stem Lesions on MRI of Acute Disseminated Encephalomyelitis, Neuromyelitis Optica, and Multiple Sclerosis

(2011) Zhengqi Lu et al.   PLoS One

Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity

(2010) Woojun Kim et al.   Multiple Sclerosis Journal

Neuromyelitis optica in France: A multicenter study of 125 patients

(2010) N. Collongues et al.   NEUROLOGY

MRI criteria for MS in patients with clinically isolated syndromes

(2010) X. Montalban et al.   NEUROLOGY

Absence of cortical demyelination in neuromyelitis optica

(2010) B. F. G. Popescu et al.   NEUROLOGY

“Cloud-like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica

(2009) Shoichi Ito et al.   ANNALS OF NEUROLOGY

Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis

(2009) James M. Stankiewicz et al.   JOURNAL OF NEUROIMAGING

Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders

(2009) S. M. Magana et al.   NEUROLOGY

Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study

(2008) Massimiliano Calabrese et al.   NEUROIMAGE